Soluble fms-like tyrosine kinase (sFlt)-1 prevents VEGF interaction with receptors located on vascular ECs blocking its stimulation, leading to maternal endothelial dysfunction in pregnancies complicated with IUGR and PE [4,5], but these observations are still obscure [8,9]. The gene discussed is VEGFA; the disease is fetal growth restriction.